Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

18.23 +0.23 (+1.25%)

Streaming Delayed Price Updated: 11:22 AM EDT, Jul 31, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	199,839
Open	18.01
Bid (Size)	18.20 (100)
Ask (Size)	18.25 (200)
Prev. Close	18.00
Today's Range	17.71 - 18.37
52wk Range	16.66 - 53.93
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Law Offices of Frank R. Cruz Encourages PROCEPT BioRobotics Corporation (PRCT) Shareholders To Inquire About Securities Fraud Class Action

July 30, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

PROCEPT BioRobotics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against PROCEPT BioRobotics Corporation - PRCT

July 30, 2026

From SkyMedia, LLC

Via GlobeNewswire

Performance

YTD	-40.8%	-40.8%
1 Month	-19.3%	-19.3%
3 Month	-24.2%	-24.2%
6 Month	-37.4%	-37.4%
1 Year	-64.5%	-64.5%

More News

Important Notice to Long-Term Shareholders of Cogent Communications Holdings, Inc. (NASDAQ: CCOI); EquipmentShare.com, Inc. (NASDAQ: EQPT); Power Solutions International, Inc. (NASDAQ: PSIX); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law

July 30, 2026

From Grabar Law Office

Via GlobeNewswire

PRCT Shareholder Alert: PROCEPT BIOROBOTICS CORPORATION Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

July 30, 2026

From Levi & Korsinsky, LLP

Via Business Wire

Deadline Approaching: PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Urged to Contact Law Offices of Howard G. Smith

July 29, 2026

From Law Offices of Howard G. Smith

Via Business Wire

PRCT INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit

July 29, 2026

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

July 29, 2026

Via Newsfile

PROCEPT BIOROBOTICS CORPORATION INVESTORS WITH LOSSES HAVE UNTIL SEPTEMBER 22, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

July 29, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

July 28, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

PROCEPT CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against PROCEPT BioRobotics Corporation and Encourages Investors to Contact the Firm

July 28, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

PRCT Lawsuit Alert: PROCEPT BioRobotics Corp. Sued for Securities Fraud after that Undisclosed Discount Program Allegations Lead to 18% Stock Drop – Investors Notified to Contact BFA Law

July 28, 2026

From Bleichmar Fonti & Auld LLP

Via Business Wire

Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages PROCEPT BioRobotics Corporation (PRCT) Shareholders To Inquire About Securities Fraud Class Action

July 28, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

INVESTOR ALERT: Securities Class Action Filed Against PROCEPT BioRobotics Corporation – Investors Encouraged to Contact Kirby McInerney LLP

July 27, 2026

From Kirby McInerney LLP

Via Business Wire

July 27, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Law Offices of Howard G. Smith Encourages PROCEPT BioRobotics Corporation (PRCT) Shareholders To Inquire About Securities Fraud Class Action

July 27, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Rosen Law Firm Urges PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Stockholders to Contact the Firm for Information About Their Rights

July 27, 2026

From The Rosen Law Firm, P.A.

Via Business Wire

Notice to Long-Term Shareholders of Cogent Communications Holdings, Inc. (NASDAQ: CCOI); EquipmentShare.com, Inc. (NASDAQ: EQPT); Photronics, Inc. (NASDAQ: PLAB); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating

July 27, 2026

From Grabar Law Office

Via GlobeNewswire

PROCEPT BIOROBOTICS CORPORATION (PRCT) INVESTOR ALERT Investors With Large Losses in PROCEPT BioRobotics Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights

July 27, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

PROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – PRCT

July 27, 2026

From The DJS Law Group

Via Business Wire

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with the Schall Law Firm

July 26, 2026

From The Schall Law Firm

Via Business Wire

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Who Suffered Losses May Be Eligible to Participate in Securities Class Action; Contact Robbins LLP for Information About Recovering Your Losses

July 24, 2026

From Robbins LLP

Via Business Wire

Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors

July 15, 2026

From Mobia Medical, Inc.

Via GlobeNewswire

PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026

July 14, 2026

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval

May 28, 2026

From PROCEPT BioRobotics

Via GlobeNewswire

What to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 Launch ↗

May 23, 2026

Via The Motley Fool

Frequently Asked Questions

Is PROCEPT BioRobotics Corporation - Common Stock publicly traded?

Yes, PROCEPT BioRobotics Corporation - Common Stock is publicly traded.

What exchange does PROCEPT BioRobotics Corporation - Common Stock trade on?

PROCEPT BioRobotics Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for PROCEPT BioRobotics Corporation - Common Stock?

The ticker symbol for PROCEPT BioRobotics Corporation - Common Stock is PRCT on the Nasdaq Stock Market

What is the current price of PROCEPT BioRobotics Corporation - Common Stock?

The current price of PROCEPT BioRobotics Corporation - Common Stock is 18.23

When was PROCEPT BioRobotics Corporation - Common Stock last traded?

The last trade of PROCEPT BioRobotics Corporation - Common Stock was at 07/31/26 11:22 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.